Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Berlin - Delayed Quote EUR

Anavex Life Sciences Corp (12X1.BE)

Compare
7.95
+0.10
+(1.25%)
At close: April 15 at 5:20:05 PM GMT+2
Loading Chart for 12X1.BE
  • Previous Close 7.85
  • Open 0.00
  • Bid --
  • Ask --
  • Day's Range 0.00 - 0.00
  • 52 Week Range 0.00 - 13.40
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) --
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date May 7, 2025 - May 12, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Recent News: 12X1.BE

View More

Performance Overview: 12X1.BE

Trailing total returns as of 4/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

12X1.BE
33.29%
S&P 500 (^GSPC)
8.25%

1-Year Return

12X1.BE
101.42%
S&P 500 (^GSPC)
6.61%

3-Year Return

12X1.BE
23.82%
S&P 500 (^GSPC)
22.86%

5-Year Return

12X1.BE
178.04%
S&P 500 (^GSPC)
93.89%

Compare To: 12X1.BE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 12X1.BE

View More

Valuation Measures

Annual
As of 4/14/2025
  • Market Cap

    661.52M

  • Enterprise Value

    555.03M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    6.83

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    --

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    --

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 12X1.BE

View More

Company Insights: 12X1.BE

Research Reports: 12X1.BE

View More